SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122466
Filing Date
2019-04-26
Accepted
2019-04-26 16:31:05
Documents
5
Period of Report
2019-06-11
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY MATERIALS d719139ddef14a.htm DEF 14A 277432
2 GRAPHIC g719139g08c20.jpg GRAPHIC 36896
3 GRAPHIC g719139g45s58.jpg GRAPHIC 27240
4 GRAPHIC g719139page036.jpg GRAPHIC 125145
5 GRAPHIC g719139page037.jpg GRAPHIC 115947
  Complete submission text file 0001193125-19-122466.txt   699374
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36183 | Film No.: 19772159
SIC: 2836 Biological Products, (No Diagnostic Substances)